Home › Funds › Saturn V Capital Management LP › AMLX
Saturn V Capital Management LP position in AMLX
AMYLYX PHARMACEUTICALS INC · Health Care
Saturn V Capital Management LP reported holding 4,624,101 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$83.0M, representing 11.91% of its reported portfolio and ranking #1 among its reported holdings. Saturn V Capital Management LP has disclosed AMLX holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Saturn V Capital Management LP's AMLX position evolved
Saturn V Capital Management LP first disclosed a stake in AMLX in Q3 2023 at 886,143 shares (US$16.2M). The position peaked in Q2 2026 at 4,624,101 shares, worth US$83.0M. Across 9 filings, Saturn V Capital Management LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,624,101 shares valued at US$83.0M — an increase of 274,216 shares quarter over quarter.. Notable position changes include a 173% increase in Q1 2025 (shares rose 81% over the following quarter), a 34% increase in Q2 2025 (shares rose 112% over the following quarter), a 41% increase in Q3 2025 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 886.14K | $16.23M | New |
| Q4 2023 | 1.10M | $16.18M | Add |
| Q4 2024 | 889.07K | $3.36M | New |
| Q1 2025 | 2.43M | $8.59M | Add |
| Q2 2025 | 3.26M | $20.90M | Add |
| Q3 2025 | 4.60M | $62.58M | Add |
| Q4 2025 | 4.50M | $54.32M | Reduce |
| Q1 2026 | 4.35M | $60.46M | Reduce |
| Q2 2026 | 4.62M | $83.05M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMLX and 13F data
AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMLX
- PERCEPTIVE ADVISORS LLC 8.33M sh · $149.69M · Q2 2026
- TCG Crossover Management, LLC 6.24M sh · $112.14M · Q2 2026
- Commodore Capital LP 5.65M sh · $101.47M · Q2 2026
- First Light Asset Management, LLC 3.02M sh · $54.30M · Q2 2026
- Siren, L.L.C. 1.48M sh · $26.59M · Q2 2026
- Almitas Capital LLC 974.88K sh · $17.51M · Q2 2026
- Jones Hill Capital LP 894.06K sh · $16.06M · Q2 2026
- Boxer Capital Management, LLC 800.00K sh · $14.37M · Q2 2026
- GREAT POINT PARTNERS LLC 700.00K sh · $12.57M · Q2 2026
- Parkman Healthcare Partners LLC 398.78K sh · $7.16M · Q2 2026
- HighVista Strategies LLC 386.08K sh · $6.93M · Q2 2026
- STEMPOINT CAPITAL LP 384.30K sh · $6.90M · Q2 2026
More on Saturn V Capital Management LP
FAQ
How long has Saturn V Capital Management LP held AMLX?
Saturn V Capital Management LP has disclosed AMLX holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
What is Saturn V Capital Management LP's current position in AMLX?
As of Q2 2026, Saturn V Capital Management LP holds 4.62M shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $83.05M, representing 11.91% of its reported portfolio and ranking #1.
Has Saturn V Capital Management LP been buying or selling AMLX?
In the latest 13F filing (Q2 2026), Saturn V Capital Management LP increased its position in AMLX. The position peaked in Q2 2026 at 4.62M shares.
Which other funds hold AMLX?
Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.